OUTCOME AND PROCEEDINGS OF 6TH ANNUAL GENERAL MEETING OF THE COMPANY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals Limited held its 6th Annual General Meeting on 29 September 2025 at 12:30 PM via video conferencing. The meeting was chaired by Managing Director Mr. Ashish Narayan Sakalkar, with all five directors in attendance, including two independent directors. Three ordinary resolutions were put to vote through remote e-voting (26–28 September) and e-voting during the meeting: (1) adoption of audited financial statements for FY ended 31 March 2025, (2) re-appointment of Whole Time Director Mrs. Saili Jayaram More via rotation, and (3) appointment of M/s Pragya & Associates as Secretarial Auditor. The company received no requests from shareholders to register as speakers, and any questions received were answered via email. The meeting concluded at 12:52 PM, with voting results to be announced within 2 working days on BSE, NSE, and the company's website.
This is a routine AGM outcome filing with no extraordinary business—only standard items like financial statement adoption and director re-appointment were voted on. No dividend, fundraising, or material strategic decision was announced, so there is unlikely to be any meaningful stock price impact. Investors should watch for the voting results, expected within two working days.